Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 31

Cited In for PubMed (Select 17187388)

1.

Neonatal adaptation in infants prenatally exposed to antidepressants--clinical monitoring using Neonatal Abstinence Score.

Forsberg L, Navér L, Gustafsson LL, Wide K.

PLoS One. 2014 Nov 3;9(11):e111327. doi: 10.1371/journal.pone.0111327. eCollection 2014.

2.

Treatment of nonpsychotic major depression during pregnancy: patient safety and challenges.

Epstein RA, Moore KM, Bobo WV.

Drug Healthc Patient Saf. 2014 Sep 18;6:109-29. doi: 10.2147/DHPS.S43308. eCollection 2014. Review.

3.
4.

Methodological challenges in using routinely collected health data to investigate long-term effects of medication use during pregnancy.

Grzeskowiak LE, Gilbert AL, Morrison JL.

Ther Adv Drug Saf. 2013 Feb;4(1):27-37. doi: 10.1177/2042098612470389.

5.

Antidepressant use in pregnancy and the risk of cardiac defects.

Huybrechts KF, Palmsten K, Avorn J, Cohen LS, Holmes LB, Franklin JM, Mogun H, Levin R, Kowal M, Setoguchi S, Hernández-Díaz S.

N Engl J Med. 2014 Jun 19;370(25):2397-407. doi: 10.1056/NEJMoa1312828.

6.

The Quebec Pregnancy Cohort--prevalence of medication use during gestation and pregnancy outcomes.

Bérard A, Sheehy O.

PLoS One. 2014 Apr 4;9(4):e93870. doi: 10.1371/journal.pone.0093870. eCollection 2014.

7.

Maternal depression, antidepressant prescriptions, and congenital anomaly risk in offspring: a population-based cohort study.

Ban L, Gibson JE, West J, Fiaschi L, Sokal R, Smeeth L, Doyle P, Hubbard RB, Tata LJ.

BJOG. 2014 Nov;121(12):1471-81. doi: 10.1111/1471-0528.12682. Epub 2014 Mar 11.

8.

Effects of maternal psychotropic drug dosage on birth outcomes.

Michielsen LA, van der Heijden FM, Janssen PK, Kuijpers HJ.

Neuropsychiatr Dis Treat. 2014;10:13-8. doi: 10.2147/NDT.S53430. Epub 2013 Dec 10.

9.

Antidepressant use in pregnant and postpartum women.

Yonkers KA, Blackwell KA, Glover J, Forray A.

Annu Rev Clin Psychol. 2014;10:369-92. doi: 10.1146/annurev-clinpsy-032813-153626. Epub 2013 Dec 2. Review.

10.

The use of central nervous system active drugs during pregnancy.

Källén B, Borg N, Reis M.

Pharmaceuticals (Basel). 2013 Oct 10;6(10):1221-86. doi: 10.3390/ph6101221.

11.

Prevalence of antidepressant use during pregnancy in Denmark, a nation-wide cohort study.

Jimenez-Solem E, Andersen JT, Petersen M, Broedbaek K, Andersen NL, Torp-Pedersen C, Poulsen HE.

PLoS One. 2013 Apr 25;8(4):e63034. doi: 10.1371/journal.pone.0063034. Print 2013.

12.

National trends in antidepressant medication treatment among publicly insured pregnant women.

Huybrechts KF, Palmsten K, Mogun H, Kowal M, Avorn J, Setoguchi-Iwata S, Hernández-Díaz S.

Gen Hosp Psychiatry. 2013 May-Jun;35(3):265-71. doi: 10.1016/j.genhosppsych.2012.12.010. Epub 2013 Jan 30.

13.

Antidepressant use in pregnancy: a critical review focused on risks and controversies.

Byatt N, Deligiannidis KM, Freeman MP.

Acta Psychiatr Scand. 2013 Feb;127(2):94-114. doi: 10.1111/acps.12042. Epub 2012 Dec 14. Review.

14.

In utero exposure to antidepressants and the use of drugs for pulmonary diseases in children.

ter Horst PG, Bos HJ, de Jong-van de Berg LT, Wilffert B.

Eur J Clin Pharmacol. 2013 Mar;69(3):541-7. doi: 10.1007/s00228-012-1314-6. Epub 2012 Jul 20.

15.

Exposure to selective serotonin reuptake inhibitors and the risk of congenital malformations: a nationwide cohort study.

Jimenez-Solem E, Andersen JT, Petersen M, Broedbaek K, Jensen JK, Afzal S, Gislason GH, Torp-Pedersen C, Poulsen HE.

BMJ Open. 2012 Jun 18;2(3). pii: e001148. doi: 10.1136/bmjopen-2012-001148. Print 2012.

16.

Antidepressant use during pregnancy and the risk of pregnancy-induced hypertension.

De Vera MA, Bérard A.

Br J Clin Pharmacol. 2012 Aug;74(2):362-9. doi: 10.1111/j.1365-2125.2012.04196.x.

17.

The effects of depression and use of antidepressive medicines during pregnancy on the methylation status of the IGF2 imprinted control regions in the offspring.

Soubry A, Murphy S, Huang Z, Murtha A, Schildkraut J, Jirtle R, Wang F, Kurtzberg J, Demark-Wahnefried W, Forman M, Hoyo C.

Clin Epigenetics. 2011 Oct 26;3:2. doi: 10.1186/1868-7083-3-2.

18.

Selective serotonin reuptake inhibitors in human pregnancy: to treat or not to treat?

Diav-Citrin O, Ornoy A.

Obstet Gynecol Int. 2012;2012:698947. doi: 10.1155/2012/698947. Epub 2011 Dec 10.

19.

Disturbed development of the enteric nervous system after in utero exposure of selective serotonin re-uptake inhibitors and tricyclic antidepressants. Part 1: Literature review.

Nijenhuis CM, Horst PG, Berg LT, Wilffert B.

Br J Clin Pharmacol. 2012 Jan;73(1):16-26. doi: 10.1111/j.1365-2125.2011.04075.x. Review.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk